Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
39 results
D1.103 - Two cases of discrepancy between fractional exhaled nitric oxide and airway eosinophils in asthma
D1.104 - Severe Bronchial Asthma Phenotypes in a Referral Tertiary Center in Saudi Arabia
D1.105 - Lichen Planus induced by treatment of severe eosinophilic asthma with biological therapy
D1.106 - Grape polyphenols reduce the concentration of LPS in patients with asthma
D1.107 - Polyphenol concentrate reduces CRP in asthma patients who have had COVID-19
D1.108 - Grape polyphenols increase the concentration of BPI in asthma patients who have had SARS-CoV-2
D1.109 - Predominance of eosinophilic pathogenetic mechanisms in a severe allergic asthma patient on biologic therapy
D1.110 - Analysis of clinical and anamnestic risk factors of bronchial asthma in children
D1.111 - Improving severe asthma through psychological management of traumatic life events
D1.112 - Managing patients with Type 2 inflammation in a joint interdisciplinary “United Airways Clinic” at Lund University Hospital, Sweden
D1.113 - Severe Asthma and Depression: the Overlooked Burden
D1.114 - The Hidden Costs of Severe Asthma Treatment: Unveiling the Iatrogenic Burden
D1.115 - Post-emergency asthma management
D2.115 - Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)
D2.116 - Occupational asthma due to Chinese yeast, Yeast and Peptone
D2.117 - The interaction of exposure to air pollutants and inflammatory markers on lung function and asthma symptoms in asthmatic patients
D2.118 - Eosinophilic Esophagitis and Atopy: A Shared Mechanism of Type 2 Inflammation
D2.119 - Real-life experience in eosinophilic granulomatosis with polyangiitis (EGPA) after 12 months with mepolizumab 300mg in specialized autoimmune and asthma units in an Universitary Hospital
D2.122 - Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report
D2.123 - The impact of wartime environmental change on the frequency of asthma diagnoses
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download